BridgeMD
New treatment option for Chronic Shoulder Pain
Official title Cognitive Functional Therapy for Chronic Shoulder Pain: Pilot and Feasibility Study
ClinicalTrials.gov ID: NCT06542666
What this study is testing
- What it's testing
- This pilot randomized controlled clinical trial (RCT) will assess the feasibility and identify the key components necessary for conducting the main RCT, which will involve the comparison of Cognitive Functional Therapy with Therapeutic Exercises in individuals with chronic shoulder pain. The main questions it aims to answer are: What barriers to the participation of the included individuals might arise?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Men and women;
- Age between 18 and 60 years;
- Presence of shoulder pain for more than 3 months;
- Pain intensity of 4 points or more on the 11-point Numeric Pain Rating Scale during the past week.
- High level of disability or moderate level of irritability.
You likely can't join if
- History of fracture or surgery of the clavicle, scapula, and/or humerus, surgical stabilization or rotator cuff repair;
- History of dislocation, instability (positive sulcus sign or apprehension test), and/or rotator cuff tear (positive drop arm test);
- Adhesive capsulitis verified by the presence of gradual onset pain associated with stiffness and reduced passive and active mobility;
- Ongoing pregnancy;
- Reproduction of shoulder pain radiating to the entire upper limb during cervical or thoracic spine tests (positive Spurling test);
- Neurological or systemic diseases that may alter muscle strength and sensitivity such as rheumatoid arthritis, fibromyalgia, lupus, gout, and...
See the full eligibility criteria
- Men and women;
- Age between 18 and 60 years;
- Presence of shoulder pain for more than 3 months;
- Pain intensity of 4 points or more on the 11-point Numeric Pain Rating Scale during the past week.
- High level of disability or moderate level of irritability.
- History of fracture or surgery of the clavicle, scapula, and/or humerus, surgical stabilization or rotator cuff repair;
- History of dislocation, instability (positive sulcus sign or apprehension test), and/or rotator cuff tear (positive drop arm test);
- Adhesive capsulitis verified by the presence of gradual onset pain associated with stiffness and reduced passive and active mobility;
- Ongoing pregnancy;
- Reproduction of shoulder pain radiating to the entire upper limb during cervical or thoracic spine tests (positive Spurling test);
- Neurological or systemic diseases that may alter muscle strength and sensitivity such as rheumatoid arthritis, fibromyalgia, lupus, gout, and diabetes;
- Corticosteroid injection in the shoulder region in the last 3 months;
- Physiotherapy treatment in the last 6 months.
The study team makes the final eligibility decision.
Where it's taking place
- João Pessoa, Paraíba, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include João Pessoa, Paraíba, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.